Rituximab Administration and Reactivation of HBV

Rituximab is a drug used for the treatment of B-cell non-Hodgkin's lymphoma, and its range of use has expanded to the treatment of collagen diseases such as idiopathic thrombocytopenic purpura and rheumatoid arthritis. One serious complication of rituximab use is the reactivation of dormant hep...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsutsumi, Yutaka, Ogasawara, Reiki, Kamihara, Yusuke, Ito, Shinichi, Yamamoto, Yoshiya, Tanaka, Junji, Asaka, Masahiro, Imamura, Masahiro
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003947/
https://www.ncbi.nlm.nih.gov/pubmed/21188195
http://dx.doi.org/10.1155/2010/182067
_version_ 1782193926772359168
author Tsutsumi, Yutaka
Ogasawara, Reiki
Kamihara, Yusuke
Ito, Shinichi
Yamamoto, Yoshiya
Tanaka, Junji
Asaka, Masahiro
Imamura, Masahiro
author_facet Tsutsumi, Yutaka
Ogasawara, Reiki
Kamihara, Yusuke
Ito, Shinichi
Yamamoto, Yoshiya
Tanaka, Junji
Asaka, Masahiro
Imamura, Masahiro
author_sort Tsutsumi, Yutaka
collection PubMed
description Rituximab is a drug used for the treatment of B-cell non-Hodgkin's lymphoma, and its range of use has expanded to the treatment of collagen diseases such as idiopathic thrombocytopenic purpura and rheumatoid arthritis. One serious complication of rituximab use is the reactivation of dormant hepatitis B virus, and prevention of this phenomenon has become an urgent issue. This paper provides a general outline of the problem through an analysis of patient cases that we and other groups have experienced to date.
format Text
id pubmed-3003947
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30039472010-12-23 Rituximab Administration and Reactivation of HBV Tsutsumi, Yutaka Ogasawara, Reiki Kamihara, Yusuke Ito, Shinichi Yamamoto, Yoshiya Tanaka, Junji Asaka, Masahiro Imamura, Masahiro Hepat Res Treat Review Article Rituximab is a drug used for the treatment of B-cell non-Hodgkin's lymphoma, and its range of use has expanded to the treatment of collagen diseases such as idiopathic thrombocytopenic purpura and rheumatoid arthritis. One serious complication of rituximab use is the reactivation of dormant hepatitis B virus, and prevention of this phenomenon has become an urgent issue. This paper provides a general outline of the problem through an analysis of patient cases that we and other groups have experienced to date. Hindawi Publishing Corporation 2010 2010-12-01 /pmc/articles/PMC3003947/ /pubmed/21188195 http://dx.doi.org/10.1155/2010/182067 Text en Copyright © 2010 Yutaka Tsutsumi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Tsutsumi, Yutaka
Ogasawara, Reiki
Kamihara, Yusuke
Ito, Shinichi
Yamamoto, Yoshiya
Tanaka, Junji
Asaka, Masahiro
Imamura, Masahiro
Rituximab Administration and Reactivation of HBV
title Rituximab Administration and Reactivation of HBV
title_full Rituximab Administration and Reactivation of HBV
title_fullStr Rituximab Administration and Reactivation of HBV
title_full_unstemmed Rituximab Administration and Reactivation of HBV
title_short Rituximab Administration and Reactivation of HBV
title_sort rituximab administration and reactivation of hbv
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003947/
https://www.ncbi.nlm.nih.gov/pubmed/21188195
http://dx.doi.org/10.1155/2010/182067
work_keys_str_mv AT tsutsumiyutaka rituximabadministrationandreactivationofhbv
AT ogasawarareiki rituximabadministrationandreactivationofhbv
AT kamiharayusuke rituximabadministrationandreactivationofhbv
AT itoshinichi rituximabadministrationandreactivationofhbv
AT yamamotoyoshiya rituximabadministrationandreactivationofhbv
AT tanakajunji rituximabadministrationandreactivationofhbv
AT asakamasahiro rituximabadministrationandreactivationofhbv
AT imamuramasahiro rituximabadministrationandreactivationofhbv

Ejemplares similares